Related Experiment Videos
Regulation and deregulation of G2 checkpoint proteins with cisplatin
M Links1, J Ribeiro, P Jackson
1Oncology Research Centre, Prince of Wales Hospital, University of New South Wales, Randwick, Australia. m.links@student.unsw.edu.au
Background:
The G2 checkpoint has a key role in the response to DNA damage. G2 arrest following DNA damage is associated with inactivation of the protein kinase cyclin B-cdc2. The role of changes in protein expression in enzyme inhibition is controversial.
Methods:
Expression of cyclin B1, cdc2, cdc25c, total protein and DNA content were examined by flow cytometry in two lung cancer cell lines. Changes in protein expression were compared to cell cycle matched controls under conditions associated with and without G2 arrest.
Results:
Total protein increased with G2 arrest and decreased with cell death. Changes in cdc2, cdc25c and p16 paralleled changes in total protein. A larger increase in cyclin B1 was seen which was due to cell cycle redistribution. Deregulation of cyclin B1 was seen with a sublethal dose of cisplatin.
Conclusions:
Our results do not support the model that changes in expression of cyclin B1 or other checkpoint proteins mediate G2 arrest after cisplatin.
Insights
DNA damage triggers the G2 checkpoint, but this study found that changes in cyclin B1 protein expression do not cause G2 arrest in lung cancer cells treated with cisplatin.
Area of Science:
- Cell cycle regulation
- DNA damage response
- Cancer biology
Background:
- The G2 checkpoint is crucial for DNA damage response, often involving cyclin B-cdc2 inactivation.
- The contribution of altered protein expression to G2 arrest is debated.
Purpose of the Study:
- To investigate the role of protein expression changes in mediating G2 arrest in lung cancer cells following DNA damage.
- To determine if cyclin B1 and other checkpoint proteins are upregulated during G2 arrest induced by cisplatin.
Main Methods:
- Flow cytometry was used to analyze cyclin B1, cdc2, cdc25c, and total protein levels in two lung cancer cell lines.
- Protein expression changes were compared between cells experiencing G2 arrest and cell cycle-matched controls.
Main Results:
- Total protein increased during G2 arrest and decreased with cell death.
- cdc2, cdc25c, and p16 levels changed in parallel with total protein.
- Increased cyclin B1 was primarily due to cell cycle redistribution, not direct upregulation.
- Deregulation of cyclin B1 was observed with sublethal cisplatin doses.
Conclusions:
- The findings do not support the hypothesis that altered expression of cyclin B1 or other checkpoint proteins drives G2 arrest after cisplatin exposure.
- Cell cycle redistribution, rather than changes in protein expression, appears to be a key factor in G2 arrest in this context.